← Назад к работе
Работы, на которые ссылается эта работа
Работ: 35
Работа: Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Kayleigh M Kew, Alieksei Seniukovich
Обзорная статья2014Цитирований: 2ABIMay statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Roberto Scicali, Antonino Di Pino, Salvatore Piro +2
Обзорная статья2020Цитирований: 2ABIMetformin and COVID-19: From cellular mechanisms to reduced mortality
Обзорная статья2020Цитирований: 2ABIStatins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
Fotios Barkas, Haralampos Milionis, Georgia Anastasiou +1
Обзорная статья2020Цитирований: 2ABIInternational register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak” (AKTIV 2)
G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov +97
Статья2021Цитирований: 2ABI